This site is intended for U.S. healthcare professionals.
Menu
Close
About
About
Experience
Efficacy & Safety
Efficacy & Safety
Once-Weekly Prophylaxis
On-Demand Bleed Control
Surgical Efficacy
Support & Resources
Support & Resources
Events
Materials
Videos
Resources for Patients and Caregivers
Additional Resources
The websites shown below are neither owned nor controlled by Pfizer.
Pfizer does not endorse and is not responsible for the content or services of these sites.
A not-for-profit organization dedicated to improving the lives of those with hemophilia and bleeding disorders worldwide.
NHF is dedicated to finding better treatments and cures for bleeding disorders and to preventing the complications of these disorders through education, advocacy, and research.
ISTH is a global, not-for-profit organization advancing the understanding, prevention, diagnosis, and treatment of thrombotic and bleeding disorders.
HTRS is a North American professional medical society dedicated to advancing care for people with bleeding and thrombotic disorders through investigator-initiated research, mentoring, and continuing medical education.
The only global conference dedicated to sharing best practices for summer camps for children in the bleeding disorders community. The Arizona Hemophilia Association conducts NACCHO yearly.
Learn how you can personalize your patients’ dosing.
** This is an optional area where footnotes can live.
BeneFIX, Coagulation Factor IX (Recombinant), is a human blood coagulation factor indicated in adults and children with hemophilia B (congenital factor IX deficiency or Christmas disease) for the on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.
Limitation of use:
BeneFIX is not indicated for induction of immune tolerance in patients with hemophilia B.
Please see full Prescribing Information for BeneFIX.
BeneFIX, Coagulation Factor IX (Recombinant), is a human blood coagulation factor indicated in adults and children with hemophilia B (congenital factor IX deficiency or Christmas disease) for the on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.
Limitation of use:
BeneFIX is not indicated for induction of immune tolerance in patients with hemophilia B.
Please see full Prescribing Information for BeneFIX.
Please see full Prescribing Information.
OK. We'll need you to sign in before we can determine if you are aligned with a sales representative.
If you select 'Yes', you will be required to enter your username and password in the sign-in form that will appear over this window.
Would you like to sign in now?